<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35373713</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1525-6049</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>44</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Renal failure</Title>
          <ISOAbbreviation>Ren Fail</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment.</ArticleTitle>
        <Pagination>
          <StartPage>625</StartPage>
          <EndPage>635</EndPage>
          <MedlinePgn>625-635</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2058405</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute kidney injury (AKI) is not a rare complication during anti-tuberculosis treatment in some patients with pulmonary tuberculosis (PTB). We aimed to develop a risk prediction model for early recognition of patients with PTB at high risk for AKI during anti-TB treatment.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This retrospective cohort study assessed the clinical baseline, and laboratory test data of 315 inpatients with active PTB who were screened for predictive factors from January 2019 to June 2020. The elements were analyzed by logistic regression analysis. A nomogram was established by the results of the logistic regression analysis. The prediction model discrimination and calibration were evaluated by the concordance index (C-index), ROC curve, and Hosmer-Lemeshow analysis.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 315 patients with PTB were enrolled (67 patients with AKI and 248 patients without AKI). Seven factors, including microalbuminuria, hematuria, cystatin-C (CYS-C), albumin (ALB), creatinine-based estimated glomerular filtration rates (eGFRs), body mass index (BMI), and CA-125 were acquired to develop the predictive model. According to the logistic regression, microalbuminuria (OR = 3.038, 95%CI 1.168-7.904), hematuria (OR = 3.656, 95%CI 1.325-10.083), CYS-C (OR = 4.416, 95%CI 2.296-8.491), and CA-125 (OR = 3.93, 95%CI 1.436-10.756) were risk parameter, while ALB (OR = 0.741, 95%CI 0.650-0.844) was protective parameter. The nomogram demonstrated good prediction in estimating AKI (C-index= 0.967, AUC = 0.967, 95%CI (0.941-0.984), sensitivity = 91.04%, specificity = 93.95%, Hosmer-Lemeshow analysis SD = 0.00054, and quantile of absolute error = 0.049).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Microalbuminuria, hematuria, ALB reduction, elevated CYS-C, and CA-125 are predictive factors for the development of AKI in patients with PTB during anti-TB treatments. The predictive nomogram based on five predictive factors is achieved good risk prediction for AKI during anti-TB treatments.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Du</LastName>
            <ForeName>Zhi Xiang</ForeName>
            <Initials>ZX</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Taizhou People's Hospital, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Fang Qun</ForeName>
            <Initials>FQ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Geriatric respiratory and critical illness, The First Affiliated Hospital of Anhui Medical University, Hefei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Zi Jian</ForeName>
            <Initials>ZJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Yijishan Hospital, Wannan Medical College, Wuhu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Da Ming</ForeName>
            <Initials>DM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Taizhou People's Hospital, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yang</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Taizhou People's Hospital, Taizhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Jiang Hua</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Diseases, Yijishan Hospital, Wannan Medical College, Wuhu, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ren Fail</MedlineTA>
        <NlmUniqueID>8701128</NlmUniqueID>
        <ISSNLinking>0886-022X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>AYI8EX34EU</RegistryNumber>
          <NameOfSubstance UI="D003404">Creatinine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014397" MajorTopicYN="Y">Tuberculosis, Pulmonary</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Risk prediction model</Keyword>
        <Keyword MajorTopicYN="N">acute kidney injury</Keyword>
        <Keyword MajorTopicYN="N">nomogram</Keyword>
        <Keyword MajorTopicYN="N">pulmonary tuberculosis</Keyword>
      </KeywordList>
      <CoiStatement>The authors declared no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>8</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35373713</ArticleId>
        <ArticleId IdType="pmc">PMC8986302</ArticleId>
        <ArticleId IdType="doi">10.1080/0886022X.2022.2058405</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>WHO.  Global tuberculosis report 2020. 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Borisov S, Maryandyshev DE.. 
A Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report. Eur Respir J. 2019;54(6):1901522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31601711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levey AS, James MT.. 
Acute kidney injury. Ann Intern Med. 2017;167(9):ITC66–ITC80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29114754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellomo R, Kellum JA, Ronco C, et al. . 
Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816–828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28364303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Wang J, Su T, ISN AKF 0by25 China Consortium, et al.. 
Community-acquired acute kidney injury: a nationwide survey in China. Am J Kidney Dis. 2017;69(5):647–657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28117208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans RDR, Hemmilä U, Craik A, et al. . 
Incidence, aetiology and outcome of community-acquired acute kidney injury in medical admissions in Malawi. BMC Nephrol. 2017;18(1):21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5237521</ArticleId>
            <ArticleId IdType="pubmed">28088183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang C-H, Chen Y-F, Wu V-C, et al. . 
Acute kidney injury due to anti-tuberculosis drugs: a five-year experience in an aging population. BMC Infect Dis. 2014;14:23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3898246</ArticleId>
            <ArticleId IdType="pubmed">24410958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakashita K, Murata K, Takahashi Y, et al. . 
A case series of acute kidney injury during anti-tuberculosis treatment. Intern Med. 2019;58(4):521–527.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6421152</ArticleId>
            <ArticleId IdType="pubmed">30333388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hendriksen JMT, Geersing GJ, Moons KGM, et al. . 
Diagnostic and prognostic prediction models. J Thromb Haemost. 2013;11(Suppl 1):129–141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23809117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guan C, Li C, Xu L, et al. . 
Risk factors of cardiac surgery-associated acute kidney injury: development and validation of a perioperative predictive nomogram. J Nephrol. 2019;32(6):937–945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31243735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang C, Murugiah K, Mahajan S, et al. . 
Enhancing the prediction of acute kidney injury risk after percutaneous coronary intervention using machine learning techniques: a retrospective cohort study. PLoS Med. 2018;15(11):e1002703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6258473</ArticleId>
            <ArticleId IdType="pubmed">30481186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Association CM Guidelines for the diagnosis and treatment of tuberculosis. Chinese Journal of Tuberculosis and Respiratory Diseases. 2001;24(2):1001–0939.</Citation>
        </Reference>
        <Reference>
          <Citation>KDIGO . KDIGO Clinical Practice Guideline for Acute Kidney Injury. 2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22890468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schetz M, Prowle J.. 
Focus on acute kidney injury 2017. Intensive Care Med. 2018;44(11):1992–1994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30187113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah AS, Amarapurkar DN.. 
Spectrum of hepatitis B and renal involvement. Liver Int. 2018;38(1):23–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28627094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhee CM, Kalantar-Zadeh K.. 
Diabetes mellitus: complex interplay between metformin, AKI and lactic acidosis. Nat Rev Nephrol. 2017;13(9):521–522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5922434</ArticleId>
            <ArticleId IdType="pubmed">28736433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onopiuk A, Tokarzewicz A, Gorodkiewicz E.. 
Cystatin C: a kidney function biomarker. Adv Clin Chem. 2015;68:57–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25858868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Laan SW, Fall T, Soumaré A, et al. . 
Cystatin C and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2016;68(9):934–945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5451109</ArticleId>
            <ArticleId IdType="pubmed">27561768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du Z-X, Liang M-M, Sun J, et al. . 
Clinical significance of serum CA-125, CA19-9 and CEA in pulmonary tuberculosis with and without type 2 diabetes. Tuberculosis (Edinb). 2017;107:104–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29050756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yilmaz A, Ece F, Bayramgürler B, et al. . 
The value of Ca 125 in the evaluation of tuberculosis activity. Respir Med. 2001;95(8):666–669.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11530955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bast
RC, Jr., Badgwell D, Lu Z, et al. . 
New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005;15(Suppl 3):274–281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16343244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kant S, Gupta H, Ahluwalia S.. 
Significance of nutrition in pulmonary tuberculosis. Crit Rev Food Sci Nutr. 2015;55(7):955–963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24915351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin H, Zhang Y, Ding Q, et al. . 
Epithelial innate immunity mediates tubular cell senescence after kidney injury. JCI Insight. 2019;4(2):e125490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6413792</ArticleId>
            <ArticleId IdType="pubmed">30674725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreno JA, Sevillano A, Gutierrez E, et al. . 
Glomerular hematuria: Cause or consequence of renal inflammation?
Int J Mol Sci. 2019;20(9):2205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6539976</ArticleId>
            <ArticleId IdType="pubmed">31060307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isobe S, Yuba M, Mori H, et al. . 
Increased pre-procedural urinary microalbumin is associated with a risk for renal functional deterioration after coronary computed tomography angiography. Int J Cardiol. 2017;230:599–603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28057367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Linder BJ, Bass EJ, Mostafid H, et al. . 
Guideline of guidelines: asymptomatic microscopic haematuria. BJU Int. 2018;121(2):176–183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28921833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ayelign B, Negash M, Genetu M, et al. . 
Immunological impacts of diabetes on the susceptibility of Mycobacterium tuberculosis. J Immunol Res. 2019;2019:6196532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6754884</ArticleId>
            <ArticleId IdType="pubmed">31583258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roca FJ, Whitworth LJ, Redmond S, et al. . 
TNF induces pathogenic programmed macrophage necrosis in tuberculosis through a mitochondrial-lysosomal-endoplasmic reticulum circuit. Cell. 2019;178(6):1344–1361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6736209</ArticleId>
            <ArticleId IdType="pubmed">31474371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennis JM, Witting PK.. 
Protective role for antioxidants in acute kidney disease. Nutrients. 2017;9(7):718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5537833</ArticleId>
            <ArticleId IdType="pubmed">28686196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Tao Y.. 
Tuberculosis-associated IgA nephropathy. J Int Med Res. 2018;46(7):2549–2557.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6124275</ArticleId>
            <ArticleId IdType="pubmed">29865923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCullough PA, Choi JP, Feghali GA, et al. . 
Contrast-Induced acute kidney injury. J Am Coll Cardiol. 2016;68(13):1465–1473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27659469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Touijer K, Scardino PT.. 
Nomograms for staging, prognosis, and predicting treatment outcomes. Cancer. 2009;115(13 Suppl):3107–3111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19544538</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
